Loading chat...
MI SB1223
Bill
Status
8/15/2012
Primary Sponsor
Dave Hildenbrand
Click for details
AI Summary
-
Prohibits pharmacists from substituting antiepileptic drugs or formulations without prior written informed consent from the prescribing physician, patient, and patient's parent, legal guardian, spouse, or legal representative.
-
Defines "antiepileptic drug" as any drug or therapeutic formulation, generic or brand, prescribed for treating epilepsy or preventing seizures.
-
Defines "interchange" to include substitutions such as generic for brand, brand for generic, different manufacturers' versions, different formulations, or different antiepileptic drug products entirely.
-
Defines "epilepsy" as a neurological condition characterized by recurrent seizures and "seizure" as an acute clinical change caused by brief electrical disturbance in the brain.
Legislative Description
Health; pharmaceuticals; pharmacist interchanging an anticonvulsant drug without notification to and consent of prescribing physician and patient; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17769.
Health, pharmaceuticals
Last Action
Referred To Committee On Health Policy
8/15/2012